Market is Projected to Display a Robust Growth with a CAGR of 47.10%

Dublin, June 20, 2017 (GLOBE NEWSWIRE) — Research and Markets has announced the addition of the “Global Micro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By Surgery, By End User, By Region, By Country): Opportunities and Forecast (2017-2022) – By Target, By Surgery, By End User, By Region, By Country” report to their offering.

Global market is projected to display a robust growth represented by a CAGR of 47.10% during 2017 – 2022, chiefly driven by several MIGS devices entering the market in next five years, rising number of glaucoma patients and rapidly aging population, high safety profile and reduced dependency on prescription eye drops.

Over the recent years, the global Micro-Invasive Glaucoma Surgery industry has been growing rapidly as the global sales of iStent device by Glaukos which was the only commercially available device in United States has witnessed rapid growth post its FDA approval in 2012. Globally, the growth in micro-invasive glaucoma surgery device market is driven by several MIGS devices entering the market in next five years, rising number of glaucoma patients and rapidly aging population.

Among the targets, Trabecular Meshwork currently dominates the Micro-Invasive Glaucoma Surgery market. Among the surgeries, Stand Alone Glaucoma surgery is projected to witness fastest growth. In terms of End User, Ambulatory Surgery Centers is predicted to grow at a higher rate than HOPDs (Hospital Outpatient Departments). Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large glaucoma population and expansion of MIGS device in the region.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *